Behavioral outcomes of monoamine oxidase deficiency: Preclinical and clinical evidence

International Review of Neurobiology

Volumn 100, Issue , 2011, Pages 13-42

  Bortolato, Marco ^a   Shih, Jean C ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Genetic polymorphisms; Knockout mice; Monoamine oxidase

Indexed keywords

3,4 DIHYDROXYMANDELIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 HYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHOL; 5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETALDEHYDE; ADRENALIN; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE REDUCTASE; AMINE OXIDASE (FLAVIN CONTAINING); CATECHOL METHYLTRANSFERASE; FLUOXETINE; HYDROXYTYROSOL; INDOLEACETIC ACID; ISOENZYME; MONOAMINE OXIDASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NORADRENALIN; PHENETHYL ALCOHOL; PHENETHYLAMINE; PHENYLACETIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SEROTONIN; TRYPTAMINE; TRYPTOPHOL; TYROSOL;

AGGRESSIVENESS; ATTENTION DEFICIT DISORDER; BINDING AFFINITY; BOOK; CATALYSIS; DEGENERATIVE DISEASE; DEPRESSION; DISEASE SEVERITY; DNA POLYMORPHISM; DRUG MECHANISM; ELECTROENCEPHALOGRAM; EMOTIONALITY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME DEGRADATION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE; EXON; GENE DELETION; HEREDITY; HUMAN; IMPULSE CONTROL DISORDER; INTRON; MENTAL DISEASE; MONOAMINE OXIDASE DEFICIENCY; NONHUMAN; NUCLEOTIDE REPEAT; OXIDATION REDUCTION STATE; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FUNCTION; PSYCHOPATHY; TRANSCRIPTION INITIATION SITE; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 80053472313     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386467-3.00002-9     Document Type: Chapter

References (205)

1. Adolfsson R., Gottfries C.G., Oreland L., Wiberg A., Winblad B. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci. 1980, 27:1029-1034.
2. Alia-Klein N., Goldstein R.Z., Kriplani A., Logan J., Tomasi D., Williams B., Telang F., Shumay E., Biegon A., Craig I.W., Henn F., Wang G.J., et al. Brain monoamine oxidase A activity predicts trait aggression. J. Neurosci. 2008, 28:5099-5104.
3. Amrein R., Hetzel W., Stabl M., Schmid-Burgk W. RIMA-a new concept in the treatment of depression with moclobemide. Int. Clin. Psychopharmacol. 1993, 7(3-4):123-132.
4. Anderson M.C., Hasan F., McCrodden J.M., Tipton K.F. Monoamine oxidase inhibitors and the cheese effect. Neurochem. Res. 1993, 18:1145-1149.
5. Anichtchik O., Sallinen V., Peitsaro N., Panula P. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). J. Comp. Neurol. 2006, 498:593-610.
6. Arai R., Karasawa N., Kurokawa K., Kanai H., Horiike K., Ito A. Differential subcellular location of mitochondria in rat serotonergic neurons depends on the presence and the absence of monoamine oxidase type B. Neuroscience 2002, 114:825-835.
7. Bach A.W., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E., Kwan S.W., Seeburg P.H., Shih J.C. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 1988, 85:4934-4938.
8. Balciuniene J., Emilsson L., Oreland L., Petterson U., Jazin E.E. Investigation of the functional effect of monoamine oxidase polymorphisms in human brain. Hum. Genet. 2002, 110:1-7.
9. Baud P., Arbilla S., Cantrill R.C., Scatton B., Langer S.Z. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. J. Pharmacol. Exp. Ther. 1985, 235:220-229.
10. Beck O., Borg S., Edman G., Fyro B., Oxenstierna G., Sedvall G. 5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factors. J. Neurochem. 1984, 43:58-61.
11. Beckmann H., Waldmeier P., Lauber J., Gattaz W.F. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment. J. Neural Transm. 1983, 57:103-110.
12. Berger W., Meindl A., van de Pol T.J., Cremers F.P., Ropers H.H., Döerner C., Monaco A., Bergen A.A., Lebo R., Warburg M., et al. Isolation of a candidate gene for Norrie disease by positional cloning. Nat. Genet. 1992, 1(3):199-203.
13. Berry M.D. The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Rev. Recent Clin. Trials 2007, 2:3-19.
14. Bialecka M., Klodowska-Duda G., Honczarenko K., Gawrońska-Szklarz B., Opala G., Safranow K., Droździk M. Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson's disease. Parkinsonism Relat. Disord. 2007, 13:224-229.
15. Binda C., Newton-Vinson P., Hubálek F., Edmondson D.E., Mattevi A. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat. Struct. Biol. 2002, 9:22-26.
16. Binda C., Li M., Hubalek F., Restelli N., Edmondson D.E., Mattevi A. Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc. Natl. Acad. Sci. USA 2003, 100:9750-9755.
17. Binda C., Wang J., Pisani L., Caccia C., Carotti A., Salvati P., Edmondson D.E., Mattevi A. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J. Med. Chem. 2007, 50:5848-5852.
18. Black G.C., Chen Z.Y., Craig I.W., Powell J.F. Dinucleotide repeat polymorphism at the MAOA locus. Nucleic Acids Res. 1991, 19:689.
19. Black K.J., Hershey T., Koller J.M., Videen T.O., Mintun M.A., Price J.L., Perlmutter J.S. A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proc. Natl. Acad. Sci. USA 2002 Dec 24, 99(26):17113-17118.
20. Blier P., de Montigny C. Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors. Neuroscience 1985, 16:949-955.
21. Bolte S., Poustka F. The recognition of facial affect in autistic and schizophrenic subjects and their first-degree relatives. Psychol. Med. 2003, 33(5):907-915.
22. Bond P.A., Cundall R.L. Properties of monoamine oxidase (MAO) in human blood platelets, plasma. Clin. Chim. Acta 1977, 80:317-326.
23. Bortolato M., Godar S.C., Davarian S., Chen K., Shih J.C. Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 2009, 34(13):2746-2757.
24. Bortolato M., Chen K., Shih J.C. The degradation of serotonin: role of MAO. Handbook of the Behavioral Neurobiology of Serotonin 2010, 203-218. Elsevier, Amsterdam. C.P. Müller, B.L. Jacobs (Eds.).
25. Bou-Flores C., Lajard A.M., Monteau R., De Maeyer E., Seif I., Lanoir J., Hilaire G. Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: possible role of a serotonin excess. J. Neurosci. 2000, 20:4646-4656.
26. Boutet I., Tanguy A., Moraga D. Molecular identification and expression of two non-P450 enzymes, monoamine oxidase A and flavin-containing monooxygenase 2, involved in phase I of xenobiotic biotransformation in the Pacific oyster, Crassostrea gigas. Biochim. Biophys. Acta 2004, 1679:29-36.
27. Boylan C.B., Bennett-Clarke C.A., Crissman R.S., Mooney R.D., Rhoades R.W. Clorgyline treatment elevates cortical serotonin and temporarily disrupts the vibrissae-related pattern in rat somatosensory cortex. J. Comp. Neurol. 2000, 427:139-149.
28. Brummett B.H., Boyle S.H., Siegler I.C., Kuhn C.M., et al. HPA axis function in male caregivers: effect of the monoamine oxidase-A gene promoter (MAOA-uVNTR). Biol. Psychol. 2008, 79(2):250-255.
29. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 1993, 262:578-580.
30. Brunner H.G., Nelen M.R., van Zandvoort P., Abeling N.G., van Gennip A.H., Wolters E.C., Kuiper M.A., Ropers H.H., van Oost B.A. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am. J. Hum. Genet. 1993, 52:1032-1039.
31. Buchsbaum M.S., Coursey R.D., Murphy D.L. The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 1976, 194:339-341.
32. Buckholtz J.W., Meyer-Lindenberg A. MAO A and the neurogenetic architecture of human aggression. Trends Neurosci. 2008, 31:120-129.
33. Cases O., Seif I., Grimsby J., Gaspar P., Chen K., Pournin S., Muller U., Aguet M., Babinet C., Shih J.C. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 1995, 268:1763-1766.
34. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 2002, 297:851-854.
35. Cazalets J.R., Gardette M., Hilaire G. Locomotor network maturation is transiently delayed in the MAOA-deficient mouse. J. Neurophysiol. 2000, 83:2468-2470.
36. Cerasa A., Gioia M.C., Labate A., Lanza P., Magariello A., Muglia M., Quattrone A. MAO A VNTR polymorphism and variation in human morphology: a VBM study. Neuroreport 2008, 19:1107-1110.
37. Cerasa A., Cherubini A., Quattrone A., Gioia M.C., Magariello A., Muglia M., Manna I., Assogna F., Caltagirone C., Spalletta G. Morphological correlates of MAO A VNTR polymorphism: new evidence from cortical thickness measurement. Behav. Brain Res. 2010, 211:118-124.
38. Chen K., Wu H.F., Grimsby J., Shih J.C. Cloning of a novel monoamine oxidase cDNA from trout liver. Mol. Pharmacol. 1994, 46:1226-1233.
39. Chen K., Wu H.F., Shih J.C. Influence of C terminus on monoamine oxidase A and B catalytic activity. J. Neurochem. 1996, 66:797-803.
40. Chen L., He M., Sibille E., Thompson A., Sarnyai Z., Baker H., Shippenberg T., Toth M. Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B. J. Neurochem. 1999, 73:647-655.
41. Chen K., Holschneider D.P., Wu W., Rebrin I., Shih J.C. A spontaneous point mutation produces monoamine oxidase A/B knock-out mice with greatly elevated monoamines and anxiety-like behavior. J. Biol. Chem. 2004, 279:39645-39652.
42. Chen Z.Y., Powell J.F., Hsu Y.P., Breakefield X.O., Craig I.W. Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomics 1992 Sep, 14(1):75-82.
43. Coccini T., Crevani A., Rossi G., Assandri F., Balottin U., Nardo R.D., Manzo L. Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder. Biomarkers 2009, 14:513-522.
44. Cohen I.L., Liu X., Schutz C., White B.N., et al. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin. Genet. 2003, 64(3):190-197.
45. Collins F.A., Murphy D.L., Reiss A.L., Sims K.B., Lewis J.G., Freund L., Karoum F., Zhu D., Maumenee I.H., Antonarakis S.E. Clinical, biochemical, and neuropsychiatric evaluation of a patient with a contiguous gene syndrome due to a microdeletion Xp11.3 including the Norrie disease locus and monoamine oxidase (MAOA and MAOB) genes. Am. J. Med. Genet. 1992, 42:127-134.
46. Consalvi V., Mardh G., Vallee B.L. Human alcohol dehydrogenases and serotonin metabolism. Biochem. Biophys. Res. Commun. 1986, 139:1009-1016.
47. Contini V., Marques F.Z., Garcia C.E., Hutz M.H., Bau C.H. MAOA-uVNTR polymorphism in a Brazilian sample: further support for the association with impulsive behaviors and alcohol dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006 Apr 5, 141B(3):305-308.
48. Costa P., Checkoway H., Levy D., Smith-Weller T., Franklin G.M., Swanson P.D., Costa L.G. Association of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am. J. Med. Genet. 1997, 74:154-156.
49. Craddock N., Daniels J., Roberts E., Rees M., McGuffin P., Owen M.J. No evidence for allelic association between bipolar disorder and monoamine oxidase A gene polymorphisms. Am. J. Med. Genet. 1995, 60:322-324.
50. Danielczyk W., Streifler M., Konradi C., Riederer P., Moll G. Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr. Scand. 1988, 78:730-736.
51. Davis L.K., Hazlett H.C., Librant A.L., Nopoulos P., Sheffield V.C., Piven J., Wassink T.H. Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147B:1145-1151.
52. Dawson G., Webb S.J., Carver L., Panagiotides H., et al. Young children with autism show atypical brain responses to fearful versus neutral facial expressions of emotion. Dev. Sci. 2004, 7(3):340-359.
53. De Colibus L., Li M., Binda C., Lustig A., Edmondson D.E., Mattevi A. Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc. Natl. Acad. Sci. USA 2005, 102:12684-12689.
54. Deckert J., Catalano M., Syagailo Y.V., Bosi M., Okladnova O., Di Bella D., Nöthen M.M., Maffei P., Franke P., Fritze J., Maier W., Propping P., et al. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 1999, 8:621-624.
55. Denney R.M., Koch H., Craig I.W. Association between monoamine oxidase A activity in human male skin fibroblasts and genotype of the MAO-A promoter-associated variable number tandem repeat. Hum. Genet. 1999, 105:542-551.
56. Despopoulos A., Weissbach H. Renal metabolism of 5-hydroxyindolacetic acid. Am. J. Physiol. 1957, 189:548-550.
57. Dlugos A.M., Palmer A.A., de Wit H. Negative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humans. J. Neural Transm. 2009, 116:1323-1334.
58. Donnelly C.H., Murphy D.L. Substrate- and inhibitor-related characteristics of human platelet. Biochem. Pharmacol. 1977, 26:853-858.
59. Dowman R., Ben-Avraham D. An artificial neural network model of orienting attention toward threatening somatosensory stimuli. Psychophysiology 2008, 45(2):229-239.
60. Dubrovina N.I., Popova N.K., Gilinskii M.A., Tomilenko R.A., Seif I. Acquisition and extinction of a conditioned passive avoidance reflex in mice with genetic knockout of monoamine oxidase A. Neurosci. Behav. Physiol. 2006, 36:335-339.
61. Edmondson D.E., Mattevi A., Binda C., Li M., Hubálek F. Structure and mechanism of monoamine oxidase. Curr. Med. Chem. 2004, 11:1983-1993.
62. Edmondson D.E., Binda C., Mattevi A. Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch. Biochem. Biophys. 2007, 464:269-276.
63. Edmondson D.E., Binda C., Wang J., Upadhyay A.K., Mattevi A. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry 2009, 48:4220-4230.
64. Edwards A.C., Dodge K.A., Latendresse S.J., Lansford J.E., Bates J.E., Pettit G.S., Budde J.P., Goate A.M., Dick D.M. MAOA-uVNTR and early physical discipline interact to influence delinquent behavior. J. Child Psychol. Psychiatry 2010 Jun, 51(6):679-687.
65. Erzurumlu R.S., Jhaveri S. Thalamic axons confer a blueprint of the sensory periphery onto the developing rat somatosensory cortex. Brain Res. Dev. Brain Res. 1990, 56:229-234.
66. Feldstein A., Williamson O. 5-Hydroxytryptamine metabolism in rat brain and liver homogenates. Br. J. Pharmacol. 1968, 34:38-42.
67. Filipenko M.L., Beilina A.G., Alekseyenko O.V., Dolgov V.V., Kudryavtseva N.N. Repeated experience of social defeats increases serotonin transporter and monoamine oxidase A mRNA levels in raphe nuclei of male mice. Neurosci. Lett. 2002, 321:25-28.
68. Foley D.L., Eaves L.J., Wormley B., Silberg J.L., et al. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch. Gen. Psychiatry 2004, 61(7):738-744.
69. Fornai F., Chen K., Giorgi F.S., Gesi M., Alessandri M.G., Shih J.C. Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study. J. Neurochem. 1999, 73:2434-2440.
70. Fowler C.J., von Knorring L., Oreland L. Platelet monoamine oxidase activity in sensation seekers. Psychiatry Res. 1980, 3(3):273-279.
71. Fowler J.S., Volkow N.D., Wang G.-J., Pappas N., Logan J., Shea C., Alexoff D., MacGregor R.R., Schlyer D.J., Zezulkova I., Wolf A.P. Brain monoamine oxidase A inhibition in cigarette smokers. Proc. Natl. Acad. Sci. USA 1996, 93:14065-14069.
72. Fowler J.S., Alia-Klein N., Kriplani A., Logan J., Williams B., Zhu W., Craig I.W., Telang F., Goldstein R., Volkow N.D., Vaska P., Wang G.J. Evidence that brain MAO A activity does not correspond to MAO A genotype in healthy male subjects. Biol. Psychiatry 2007, 62:355-358.
73. Fox H.H., Gibas J.T. Synthetic tuberculostats. V. Alkylidene derivatives of isonicotinylhydrazine. J. Org. Chem. 1953, 18:983-989.
74. Furlong R.A., Ho L., Rubinsztein J.S., Walsh C., Paykel E.S., Rubinsztein D.C. Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter. Am. J. Med. Genet. 1999, 88:398-406.
75. Garpenstrand H., Ekblom J., Forslund K., Rylander G., Oreland L. Platelet monoamine oxidase activity is related to MAOB intron 13 genotype. J. Neural Transm. 2000, 107:523-530.
76. Garrick N.A., Murphy D.L. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain. Psychopharmacology 1980, 72:27-33.
77. Geha R.M., Chen K., Shih J.C. Phe(208) and Ile(199) in human monoamine oxidase A and B do not determine substrate and inhibitor specificities as in rat. J. Neurochem. 2000, 75:1304-1309.
78. Geha R.M., Rebrin I., Chen K., Shih J.C. Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid. J. Biol. Chem. 2001, 276:9877-9882.
79. Girmen A.S., Baenziger J., Hotamisligil G.S., Konradi C., Shalish C., Sullivan J.L., Breakefield X.O. Relationship between platelet monoamine oxidase B activity and alleles at the MAOB locus. J. Neurochem. 1992, 59:2063-2066.
80. Godar S.C., Bortolato M., Frau R., Dousti M., Chen K., Shih J.C. Maladaptive defensive behaviours in monoamine oxidase A-deficient mice. Int. J. Neuropsychopharmacol. 2011, in press.
81. Gottowik J., Cesura A.M., Malherbe P., Lang G., Da Prada M. Characterisation of wild-type and mutant forms of human monoamine oxidase A and B expressed in a mammalian cell line. FEBS Lett. 1993, 317:152-156.
82. Griebel G., Curet O., Perrault G., Sanger D.J. Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels. Neuropharmacology 1998, 37(7):927-935.
83. Grimsby J., Chen K., Wang L.J., Lan N.C., Shih J.C. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc. Natl. Acad. Sci. USA 1991, 88:3637-3641.
84. Grimsby J., Toth M., Chen K., Kumazawa T., Klaidman L., Adams J.D., Karoum F., Gal J., Shih J.C. Increased stress response and b-phenylethylamine in MAOB-deficient mice. Nat. Genet. 1997, 17:206-210.
85. Grünblatt E., Schlösser R., Fischer P., Fischer M.O., Li J., Koutsilieri E., Wichart I., Sterba N., Rujescu D., Möller H.J., Adamcyk W., Dittrich B., et al. Oxidative stress related markers in the "VITA" and the centenarian projects. Neurobiol. Aging 2005, 26:429-438.
86. Gur R.E., Loughead J., Kohler C.G., Elliott M.A., et al. Limbic activation associated with misidentification of fearful faces and flat affect in schizophrenia. Arch. Gen. Psychiatry 2007, 64(12):1356-1366.
87. Hall J., Whalley H.C., McKirdy J.W., Romaniuk L., et al. Overactivation of fear systems to neutral faces in schizophrenia. Biol. Psychiatry 2008, 64(1):70-73.
88. Hauptmann N., Shih J.C. 2-Naphthylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. Life Sci. 2001, 68:1231-1241.
89. Hebebrand J., Klug B. Specification of the phenotype required for men with monoamine oxidase type A deficiency. Hum. Genet. 1995, 96(3):372-376.
90. Helander A., Beck O., Jacobsson G., Lowenmo C., Wikstrom T. Time course of ethanol-induced changes in serotonin metabolism. Life Sci. 1993, 53:847-855.
91. Hinds H.L., Hendriks R.W., Craig I.W., Chen Z.Y. Characterization of a highly polymorphic region near the first exon of the human MAOA gene containing a GT dinucleotide and a novel VNTR motif. Genomics 1992, 13(3):896-897.
92. Ho S.L., Kapadi A.L., Ramsden D.B., Williams A.C. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann. Neurol. 1995, 37:403-405.
93. Huang Y.-y., Cate S.P., Battistuzzi C., Oquendo M.A., Brent D., Mann J.J. An association between a functional polymorphism in the monoamine oxidase A gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 2004, 29:1498-1505.
94. Hurwitz B.E., Dietrich W.D., McCabe P.M., Watson B.D., et al. Sensory-motor deficit and recovery from thrombotic infarction of the vibrissal barrel-field cortex. Brain Res. 1990, 512(2):210-220.
95. Jahng J.W., Houpt T.A., Wessel T.C., Chen K., Shih J.C., Joh T.H. Localization of monoamine oxidase A and B mRNA in the rat brain by in situ hybridization. Synapse 1997, 25:30-36.
96. Jahng J.W., Houpt T.A., Joh T.H., Son J.H. Differential expression of monoamine oxidase A, serotonin transporter, tyrosine hydroxylase and norepinephrine transporter mRNA by anorexia mutation and food deprivation. Dev. Brain Res. 1998, 107:241-246.
97. Johnston J.P. Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol. 1968, 17:1285-1297.
98. Jonsson E.G., Norton N., Gustavsson J.P., Oreland L., Owen M.J., Sedvall G.C. A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J. Psychiatr. Res. 2000, 34:239-244.
99. Kang S.J., Scott W.K., Li Y.J., Hauser M.A., van der Walt J.M., Fujiwara K., Mayhew G.M., West S.G., Vance J.M., Martin E.R. Family-based case-control study of MAOA and MAOB polymorphisms in Parkinson disease. Mov. Disord. 2006, 21:2175-2180.
100. Kawada Y., Hattori M., Dai X.Y., Nanko S. Possible association between monoamine oxidase A gene and bipolar affective disorder. Am. J. Hum. Genet. 1995, 56:335-336.
101. Kearney E.B., Salach J.I., Walker W.H., Seng R.L., Kenney W., Zeszotek E., Singer T.P. The covalently-bound flavin of hepatic monoamine oxidase. 1. Isolation and sequence of a flavin peptide and evidence for binding at the 8alpha position. Eur. J. Biochem. 1971, 24:321-327.
102. Kennedy S.H. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors. J Psychiatry Neurosci. 1997, 22:127-131.
103. Kinnally E.L., Huang Y.Y., Haverly R., Burke A.K., Galfalvy H., Brent D.P., Oquendo M.A., Mann J.J. Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women. Psychiatr. Genet. 2009 Jun, 19(3):126-133.
104. Kim J.J., Shih J.C., Chen K., Chen L., Bao S., Maren S., Anagnostaras S.G., Fanselow M.S., De Maeyer E., Seif I., Thompson R.F. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc. Natl. Acad. Sci. USA 1997, 94(11):5929-5933.
105. Kim-Cohen J., Caspi A., Taylor A., Williams B., Newcombe R., Craig I.W., Moffitt T.E. MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol. Psychiatry. 2006 Oct, 11(10):903-913.
106. Klinteberg B., von Knorring L., Oreland L. On the psychobiology of impulsivity. On the psychobiology of personality: essays in honour of Marvin Zuckerman 2004, 455-478. Elsevier, Amsterdam. R.M. Stelmack (Ed.).
107. Knoll J., Magyar K. Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol. 1972, 5:393-408.
108. Kobayashi S., Takahara K., Kamijo K. Monoamine oxidase in frog liver and brain. Comp. Biochem. Physiol. C 1981, 69:179-183.
109. Konradi C., Kornhuber J., Froelich L., Fritze J., Heinsen H., Beckmann H., Schulz E., Riederer P. Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique. Neuroscience 1989, 33:383-400.
110. Kosenko E., Kaminsky Y., Kaminsky A., Valencia M., Lee L., Hermenegildo C., Felipo V. Superoxide production and antioxidant enzymes in ammonia intoxication in rats. Free Radic. Res. 1997, 27:637-644.
111. Kurth J.H., Kurth M.C., Poduslo S.E., Schwankhaus J.D. Association of a monoamine oxidase B allele with Parkinson's disease. Ann. Neurol. 1993, 33:368-372.
112. Kuroki T., Tsutsumi T., Hirano M., Matsumoto T., Tatebayashi Y., Nishiyama K., Uchimura H., Shiraishi A., Nakahara T., Nakamura K. Behavioral sensitization to beta-phenylethylamine (PEA): enduring modifications of specific dopaminergic neuron systems in the rat. Psychopharmacology (Berl). 1990, 102(1):5-10.
113. Lan N.C., Chen C.H., Shih J.C. Expression of functional human monoamine oxidase A and B cDNAs in mammalian cells. J. Neurochem. 1989, 52:1652-1654.
114. Lan N.C., Heinzmann C., Gal A., Klisak I., Orth U., Lai E., Grimsby J., Sparkes R.S., Mohandas T., Shih J.C. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease. Genomics 1989, 4:552-559.
115. Lee B.T., Ham B.J. Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Neuroreport 2008, 19(5):515-519.
116. Lenders J.W., Eisenhofer G., Abeling N.G., Berger W., Murphy D.L., Konings C.H., Wagemakers L.M., Kopin I.J., Karoum F., van Gennip A.H., Brunner H.G. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes. J. Clin. Invest. 1996, 97:1010-1019.
117. Levy E.R., Powell J.F., Buckle V.J., Hsu Y.P., Breakefield X.O., Craig I.W. Localization of human monoamine oxidase-A gene to Xp11.23-11.4 by in situ hybridization: implications for Norrie disease. Genomics 1989, 5(2):368-370.
118. Li M., Hubálek F., Newton-Vinson P., Edmondson D.E. High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae. Protein Expr. Purif. 2002, 24:152-162.
119. Li J., Wang Y., Hu S., Zhou R., Yu X., Wang B., Guan L., Yang L., Zhang F., Faraone S.V. The monoamine oxidase B gene exhibits significant association to ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008, 147:370-374.
120. Lim L.C., Powell J.F., Murray R., Gill M. Monoamine oxidase A gene and bipolar affective disorder. Am. J. Hum. Genet. 1994, 54:1122-1124.
121. Lim L.C., Powell J., Sham P., Castle D., Hunt N., Murray R., Gill M. Evidence for genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. Am. J. Med. Genet. 1995, 1995(60):325-331.
122. Luque J.M., Kwan S.W., Abell C.W., Da Prada M., Richards J.G. Cellular expression of mRNAs encoding monoamine oxidases A and B in the rat central nervous system. J. Comp. Neurol. 1995, 363:665-680.
123. Luque J.M., Bleuel Z., Hendrickson A., Richards J.G. Detection of MAO-A and MAO-B mRNAs in monkey brainstem by cross-hybridization with human oligonucleotide probes. Brain Res. Mol. Brain Res. 1996, 36:357-360.
124. Ma J., Yoshimura M., Yamashita E., Nakagawa A., Ito A., Tsukihara T. Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J. Mol. Biol. 2004, 338:103-114.
125. Mann J., Chiu E. Platelet monoamine oxidase activity in Huntington's chorea. J. Neurol. Neurosurg. Psychiatry 1978, 41:809-812.
126. Maura G., Vaccari A. Relationships between age of submission to environmental stress, and monoamine oxidase activity in rats. Experientia 1975, 31:191-193.
127. Megens A.A., Niemegeers C.J., Awouters F.H. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol. J. Pharmacol. Exp. Ther. 1992 Jan, 260(1):160-167.
128. Mejia J.M., Ervin F.R., Palmour R.M., Tremblay R.E. Aggressive behavior and Brunner syndrome: no evidence for the C936T mutation in a population sample. Am. J. Med. Genet. 2001, 105:396-397.
129. Mejia J.M., Ervin F.R., Baker G.B., Palmour R.M. Monoamine oxidase inhibition during brain development induces pathological aggressive behavior in mice. Biol. Psychiatry 2002, 52:811-821.
130. Mendlewicz J., Youdim M.B. L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation. Br. J. Psychiatry 1983, 142:508-511.
131. Meyer-Lindenberg A., Buckholtz J.W., Kolachana B.R., Hariri A.R., Pezawas L., Blasi G., Wabnitz A., Honea R., Verchinski B., Callicott J.H., Egan M., Matty V., et al. Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc. Natl. Acad. Sci. USA 2006, 103:6269-6274.
132. Morishima M., Harada N., Hara S., Sano A., Seno H., Takahashi A., Morita Y., Nakaya Y. Monoamine oxidase A activity and norepinephrine level in hippocampus determine hyperwheel running in SPORTS rats. Neuropsychopharmacology 2006, 31:2627-2638.
133. Muramatsu T., Matsushita S., Kanba S., Higuchi S., Manki H., Suzuki E., Asai M. Monoamine oxidase genes polymorphisms and mood disorder. Am. J. Med. Genet. 1997, 74:494-496.
134. Murphy D.L., Sims K.B., Karoum F., de la Chapelle A., Norio R., Sankila E.M., Breakefield X.O. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase. J. Neurochem. 1990, 54:242-247.
135. Nedic G., Pivac N., Hercigonja D.K., Jovancevic M., Curkovic K.D., Muck-Seler D. Platelet monoamine oxidase activity in children with attention-deficit/hyperactivity disorder. Psychiatry Res. 2010, 175:252-255.
136. Newton-Vinson P., Hubalek F., Edmondson D.E. High-level expression of human liver monoamine oxidase B in Pichia pastoris. Protein Expr. Purif. 2000, 20:334-345.
137. Nicotra A., Senatori O. Changes in monoamine oxidase activity by mitochondria isolated from late embryos of Bufo bufo. Comp. Biochem. Physiol. C 1988, 89:5-9.
138. Obata T. Semicarbazide-sensitive amine oxidase (SSAO) in the brain. Neurochem. Res. 2002, 27:263-268.
139. O'Brien P.J., Siraki A.G., Shangari N. Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health. Crit. Rev. Toxicol. 2005, 35:609-662.
140. Olsen C.M., Winder D.G. Operant sensation seeking engages similar neural substrates to operant drug seeking in C57 mice. Neuropsychopharmacology 2009, 34:1685-1694.
141. O'Reilly R., Davis B.A., Durden D.A., Thorpe L., Machnee H., Boulton A.A. Plasma phenylethylamine in schizophrenic patients. Biol. Psychiatry 1991, 30:145-150.
142. Oreland L., Hallman J. The correlation between platelet MAO activity and personality: short review of findings and a discussion on possible mechanisms. Prog. Brain Res. 1995, 106:77-84.
143. Oreland L., Nilsson K., Damberg M., Hallman J. Monoamine oxidases: activities, genotypes and the shaping of behaviour. J. Neural Transm. 2007, 114:817-822.
144. Oxenstierna G., Edman G., Iselius L., Oreland L., Ross S.B., Sedvall G. Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals-a genetic study. J. Psychiatr. Res. 1986, 20:19-29.
145. Ozelius L., Hsu Y.P., Bruns G., Powell J.F., Chen S., Weyler W., Utterback M., Zucker D., Haines J., Trofatter J.A., et al. Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism. Genomics 1988, 3:53-58.
146. Passamonti L., Fera F., Magariello A., Cerasa A., Gioia M.C., Muglia M., Nicoletti G., Gallo O., Provinciali L., Quattrone A. Monoamine oxidase-a genetic variations influence brain activity associated with inhibitory control: new insight into the neural correlates of impulsivity. Biol. Psychiatry 2006, 59:334-340.
147. Pedersen N.L., Oreland L., Reynolds C., McClearn G.E. Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together. Psychiatry Res. 1993, 46:239-251.
148. Peters J.R., Vallie B., Difronzo M., Donaldson S.T. Role of dopamine D1 receptors in novelty seeking in adult female Long-Evans rats. Brain Res. Bull. 2007, 74:232-236.
149. Phillips M.L., Williams L., Senior C., Bullmore E.T., et al. A differential neural response to threatening and non-threatening negative facial expressions in paranoid and non-paranoid schizophrenics. Psychiatry Res. 1999, 92(1):11-31.
150. Picazo O., Chuc-Meza E., Anaya-Martinez V., Jimenez I., Aceves J., Garcia-Ramirez M. 6-Hydroxydopamine lesion in thalamic reticular nucleus reduces anxiety behaviour in the rat. Behav. Brain Res. 2009 Feb 11, 197(2):317-322.
151. Popova N.K., Skrinskaya Y.A., Amstislavskaya T.G., Vishnivetskaya G.B., Seif I., de Meier E. Behavioral characteristics of mice with genetic knockout of monoamine oxidase type A. Neurosci. Behav. Physiol. 2001, 31:597-602.
152. Popova N.K., Maslova L.N., Morosova E.A., Bulygina V.V., Seif I. MAO A knockout attenuates adrenocortical response to various kinds of stress. Psychoneuroendocrinology 2006, 31:179-186.
153. Preisig M., Bellivier F., Fenton B.T., Baud P., Berney A., Courtet P., Hardy P., Golaz J., Leboyer M., Mallet J., Matthey M.L., Mouthon D., et al. Association between bipolar disorder and monoamine oxidase A gene polymorphisms: results of a multicenter study. Am. J. Psychiatry 2000, 157:948-955.
154. Quitkin F.M., Liebowitz M.R., Stewart J.W., McGrath P.J., Harrison W., Rabkin J.G., Markowitz J., Davies S.O. l-Deprenyl in atypical depressives. Arch. Gen. Psychiatry 1984, 41:777-781.
155. Reist C., Haier R.J., DeMet E., Chicz-DeMet A. Platelet MAO activity in personality disorders and normal controls. Psychiatry Res. 1990, 33:221-227.
156. Ribasés M., Ramos-Quiroga J.A., Hervás A., Bosch R., Bielsa A., Gastaminza X., Artigas J., Rodriguez-Ben S., Estivill X., Casas M., Cormand B., Bayés M. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol. Psychiatry 2009, 14:71-85.
157. Robinson D.S., Gilmor M.L., Yang Y., Moonsammy G., Azzaro A.J., Oren D.A., Campbell B.J. Treatment effects of selegiline transdermal system on symptoms of major depressive disorder: a meta-analysis of short-term, placebo-controlled, efficacy trials. Psychopharmacol. Bull. 2007, 40:15-28.
158. Roohi J., DeVincent C.J., Hatchwell E., Gadow K.D. Association of a monoamine oxidase-a gene promoter polymorphism with ADHD and anxiety in boys with autism spectrum disorder. J. Autism Dev. Disord. 2009 Jan, 39(1):67-74.
159. Rubinsztein D.C., Leggo J., Goodburn S., Walsh C., Jain S., Paykel E.S. Genetic association between monoamine oxidase A microsatellite and RFLP alleles and bipolar affective disorder: analysis and meta-analysis. Hum. Mol. Genet. 1996, 5:779-782.
160. Ruchkin V.V., Koposov R.A., af Klinteberg B., Oreland L., Grigorenko E.L. Platelet MAO-B, personality, and psychopathology. J. Abnorm. Psychol. 2005, 114:477-482.
161. Saba A., Chiellini G., Frascarelli S., Marchini M., Ghelardoni S., Raffaelli A., Tonacchera M., Vitti P., Scanlan T.S., Zucchi R. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology 2010, 151(10):5063-5073.
162. Sabelli H.C., Javaid J.I. Phenylethylamine modulation of affect: therapeutic and diagnostic implications. J. Neuropsychiatry Clin. Neurosci. 1995, 7(1):6-14.
163. Sabol S.Z., Hu S., Hamer D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 1998, 103:273-279.
164. Salichon N., Gaspar P., Upton A.L., Picaud S., Hanoun N., Hamon M., De Maeyer E., Murphy D.L., Mossner R., Lesch K.P., Hen R., Seif I. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J. Neurosci. 2001, 21:884-896.
165. Samochowiec J., Lesch K.P., Rottmann M., Smolka M., Syagailo Y.V., Okladnova O., Rommelspacher H., Winterer G., Schmidt L.G., Sander T. Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res. 1999 Apr 19, 86(1):67-72.
166. Sanders M.J., Dietrich W.D., Green E.J. Behavioral, electrophysiological, and histopathological consequences of mild fluid-percussion injury in the rat. Brain Res. 2001, 904(1):141-144.
167. Sandler M., Glover V., Clow A., Jarman J. Monoamine oxidase-B, monoamine oxidase-B inhibitors, and Parkinson's disease. A role for superoxide dismutase?. Adv. Neurol. 1993, 60:238-241.
168. Saura J., Richards J.G., Mahy N. Age-related changes on MAO in Bl/C57 mouse tissues: a quantitative radioautographic study. J. Neural Transm. 1994, 41(Suppl.):89-94.
169. Schilling B., Lerch K. Cloning, sequencing and heterologous expression of the monoamine oxidase gene from Aspergillus niger. Mol. Gen. Genet. 1995, 247(4):430-438.
170. Schuback D.E., Mulligan E.L., Sims K.B., Tivol E.A., Greenberg B.D., Chang S.F., Yang S.L., Mau Y.C., Shen C.Y., Ho M.S., Yang N.H., Butler M.G., et al. Screen for MAOA mutations in target human groups. Am. J. Med. Genet. 1999, 88:25-28.
171. Scott A.L., Bortolato M., Chen K., Shih J.C. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport 2008, 19:739-743.
172. Setini A., Pierucci F., Senatori O., Nicotra A. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2005, 140:153-161.
173. Shabanov P.D., Lebedev A.A., Meshcherov Sh.K., Strel'tsov V.F. The effects of neurochemical lesioning of dopaminergic terminals in early ontogenesis on behavior in adult rats. Neurosci. Behav. Physiol. 2005 Jun, 35(5):535-544.
174. Sharp T., Gartside S.E., Umbers V. Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release. Eur. J. Pharmacol. 1997, 320:15-19.
175. Shekim W.O., Bylund D.B., Alexson J., Glaser R.D., Jones S.B., Hodges K., Perdue S. Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res. 1986, 18:179-188.
176. Shih J.C., Eiduson S. Multiple forms of monoamine oxidase in the developing brain. Nature 1969, 224:1309-1310.
177. Shih J.C., Thompson R.F. Monoamine oxidase in neuropsychiatry and behavior. Am. J. Hum. Genet. 1999, 65:593-598.
178. Simpson G.M., Shih J.C., Chen K., Flowers C., Kumazawa T., Spring B. Schizophrenia, monoamine oxidase activity, and cigarette smoking. Neuropsychopharmacology 1999, 20:392-394.
179. Sims K.B., de la Chapelle A., Norio R., Sankila E.M., Hsu Y.P., Rinehart W.B., Corey T.J., Ozelius L., Powell J.F., Bruns G., et al. Monoamine oxidase deficiency in males with an X chromosome deletion. Neuron 1989, 2:1069-1076.
180. Sims K.B., Ozelius L., Corey T., Rinehart W.B., Liberfarb R., Haines J., Chen W.J., Norio R., Sankila E., de la Chapelle A., et al. Norrie disease gene is distinct from the monoamine oxidase genes. Am. J. Hum. Genet. 1989, 45:424-434.
181. Sotnikova T.D., Budygin E.A., Jones S.R., Dykstra L.A., Caron M.G., Gainetdinov R.R. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. J. Neurochem. 2004 Oct, 91(2):362-373.
182. Steckler T., Rammes G., Sauvage M., van Gaalen M.M., et al. Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice. J. Psychiatr. Res. 2001, 35(1):29-42.
183. Straube T., Schmidt S., Weiss T., Mentzel H.J., et al. Dynamic activation of the anterior cingulate cortex during anticipatory anxiety. Neuroimage 2009, 44(3):975-981.
184. Surguladze S., Russell T., Kucharska-Pietura K., Travis M.J., et al. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biol. Psychiatry 2006, 60(5):423-431.
185. Svensson S., Some M., Lundsjo A., Helander A., Cronholm T., Hoog J.O. Activities of human alcohol dehydrogenases in the metabolic pathways of ethanol and serotonin. Eur. J. Biochem. 1999, 262:324-329.
186. Szymanski H.V., Naylor E.W., Karoum F. Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients. Biol. Psychiatry 1987, 22:194-198.
187. Tariot P.N., Cohen R.M., Sunderland T., Newhouse P.A., Yount D., Mellow A.M., Weingartner H., Mueller E.A., Murphy D.L. L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition. Arch. Gen. Psychiatry 1987, 44:427-433.
188. Thompson A.M. Serotonin immunoreactivity in auditory brainstem neurons of the postnatal monoamine oxidase-A knockout mouse. Brain Res. 2008, 1228:58-67.
189. Thompson A.M., Thompson G.C. Serotonin-immunoreactive neurons in the postnatal MAO-A KO mouse lateral superior olive project to the inferior colliculus. Neurosci. Lett. 2009, 460:47-51.
190. Tolbert S.R., Fuller M.A. Selegiline in treatment of behavioral and cognitive symptoms of Alzheimer disease. Ann. Pharmacother. 1996, 30:1122-1129.
191. Udenfriend S., Titus E., Weissbach H., Peterson R.E. Biogenesis and metabolismof 5-hydroxyindole compounds. J. Biol. Chem. 1956, 219:335-344.
192. Upadhyay A.K., Wang J., Edmondson D.E. Comparison of the structural properties of the active site cavities of human and rat monoamine oxidase A and B in their soluble and membrane-bound forms. Biochemistry 2008, 47:526-536.
193. Upton A.L., Salichon N., Lebrand C., Ravary A., Blakely R., Seif I., Gaspar P. Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock -out mice: possible role of 5-HT uptake in retinal ganglion cells during development. J. Neurosci. 1999, 19:7007-7024.
194. van Gaalen M.M., Brueggeman R.J., Bronius P.F., Schoffelmeer A.N., Vanderschuren L.J. Behavioral disinhibition requires dopamine receptor activation. Psychopharmacology (Berl). 2006 Jul, 187(1):73-85.
195. Vitalis T., Cases O., Callebert J., Launay J.M., Price D.J., Seif I., Gaspar P. Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: determination of a sensitive developmental period. J. Comp. Neurol. 1998, 393:169-184.
196. von Knorring L., Oreland L., Winblad B. Personality traits related to monoamine oxidase activity in platelets. Psychiatry Res. 1984, 12:11-26.
197. Whibley A., Urquhart J., Dore J., Willatt L., Parkin G., Gaunt L., Black G., Donnai D., Raymond F.L. Deletion of MAOA and MAOB in a male patient causes severe developmental delay, intermittent hypotonia and stereotypical hand movements. Eur. J. Hum. Genet. 2010, 18:1095-1099.
198. Whitaker-Azmitia P.M., Zhang X., Clarke C. Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies. Neuropsychopharmacology 1994, 11(2):125-132.
199. Williams L.M., Gatt J.M., Kuan S.A., Dobson-Stone C., et al. A polymorphism of the MAOA gene is associated with emotional brain markers and personality traits on an antisocial index. Neuropsychopharmacology 2009, 34(7):1797-1809.
200. Williams R.B., Marchuk D.A., Gadde K.M., Barefoot J.C., Grichnik K., Helms M.J., Kuhn C.M., Lewis J.G., Schanberg S.M., Stafford-Smith M., Suarez E.C., Clary G.L., Svenson I.K., Siegler I.C. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003 Mar, 28(3):533-541.
201. Wu H.F., Chen K., Shih J.C. Site-directed mutagenesis of monoamine oxidase A and B: role of cysteines. Mol. Pharmacol. 1993, 43:888-893.
202. Wylie C.J., Hendricks T.J., Zhang B., Wang L., Lu P., Leahy P., Fox S., Maeno H., Deneris E.S. Distinct transcriptomes define rostral and caudal serotonin neurons. J. Neurosci. 2010 Jan 13, 30(2):670-684.
203. Youdim M.B., Collins G.G., Sandler M. Multiple forms of rat brain monoamine oxidase. Nature 1969, 223:626-628.
204. Yu Y.W., Tsai S.J., Hong C.J., Chen T.J., Chen M.C., Yang C.W. Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 2005 Sep, 30(9):1719-1723.
205. Zucchi R., Chiellini G., Scanlan T.S., Grandy D.K. Trace amine-associated receptors and their ligands. Br. J. Pharmacol. 2006, 149:967-978.